KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Goodwill (2016 - 2026)

Biogen has reported Goodwill over the past 18 years, most recently at $6.5 billion for Q1 2026.

  • For Q1 2026, Goodwill changed 0.18% year-over-year to $6.5 billion; the TTM value through Mar 2026 reached $6.5 billion, changed 0.18%, while the annual FY2025 figure was $6.5 billion, 0.19% changed from the prior year.
  • Goodwill for Q1 2026 was $6.5 billion at Biogen, roughly flat from $6.5 billion in the prior quarter.
  • Over five years, Goodwill peaked at $6.8 billion in Q3 2023 and troughed at $5.7 billion in Q3 2022.
  • A 5-year average of $6.2 billion and a median of $6.2 billion in 2024 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: grew 18.57% in 2023 and later fell 4.73% in 2024.
  • Year by year, Goodwill stood at $5.7 billion in 2022, then grew by 8.18% to $6.2 billion in 2023, then rose by 4.18% to $6.5 billion in 2024, then grew by 0.19% to $6.5 billion in 2025, then fell by 0.04% to $6.5 billion in 2026.
  • Business Quant data shows Goodwill for BIIB at $6.5 billion in Q1 2026, $6.5 billion in Q4 2025, and $6.5 billion in Q3 2025.